Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Natali

Showing results (321-330 of 328) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 328 results.
International Journal of Cancer|May 16, 1995
Bispecific monoclonal antibody anti-CD3 x anti-tenascin: an immunotherapeutic agent for human gliomaL Davico Bonino, L B De Monte, G C Spagnoli, et al.
Tissue Antigens|August 25, 2000
Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatmentG Frumento, S Franchello, G L Palmisano, et al.
Tissue Antigens|February 11, 1998
HLA-C heavy chains free of beta2-microglobulin: distribution in normal tissues and neoplastic lesions of non-lymphoid origin and interferon-gamma responsivenessP Giacomini, A Beretta, M R Nicotra, et al.
Cancer Research|June 11, 1999
Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell linesP Giacomini, E Giorda, R Fraioli, et al.
British Journal of Cancer|December 1, 1996
Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomasM Olivero, M Rizzo, R Madeddu, et al.
British Journal of Cancer|June 7, 2006
Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumoursS Uccini, C Colarossi, S Scarpino, et al.
Human Immunology|January 4, 2001
HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expressionP Paul, N Rouas-Freiss, P Moreau, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 15, 2003
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic riskF Podo, F Sardanelli, R Canese, et al.
Pageof 33

Showing results (321-330 of 328) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 328 results.
International Journal of Cancer|May 16, 1995
Bispecific monoclonal antibody anti-CD3 x anti-tenascin: an immunotherapeutic agent for human gliomaL Davico Bonino, L B De Monte, G C Spagnoli, et al.
Tissue Antigens|August 25, 2000
Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatmentG Frumento, S Franchello, G L Palmisano, et al.
Tissue Antigens|February 11, 1998
HLA-C heavy chains free of beta2-microglobulin: distribution in normal tissues and neoplastic lesions of non-lymphoid origin and interferon-gamma responsivenessP Giacomini, A Beretta, M R Nicotra, et al.
Cancer Research|June 11, 1999
Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell linesP Giacomini, E Giorda, R Fraioli, et al.
British Journal of Cancer|December 1, 1996
Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomasM Olivero, M Rizzo, R Madeddu, et al.
British Journal of Cancer|June 7, 2006
Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumoursS Uccini, C Colarossi, S Scarpino, et al.
Human Immunology|January 4, 2001
HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expressionP Paul, N Rouas-Freiss, P Moreau, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 15, 2003
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic riskF Podo, F Sardanelli, R Canese, et al.
Pageof 33